, Keywords: C-H activation ? Isotopic labelling ? Nanoparticles ? Hydrogen isotope exchange ? Oligonucleotides

, Nucleosides and Nucleotides as Antitumor and Antiviral Agents, 1993.

C. F. Bennett and E. E. Swayze, Ann. Rev. Pharmacol. Toxicol, vol.50, pp.259-293, 2010.

A. Fire, S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver et al., Nature, vol.391, pp.806-811, 1998.

A. Wittrup and J. Lieberman, Nat. Rev. Genet, vol.16, pp.543-552, 2015.

S. Song, J. Lee, N. Wang, N. Ince, J. Ouyang et al., Nat. Rev. Genet, vol.9, pp.329-340, 2003.

J. Atzrodt, V. Derdau, W. J. Kerr, and M. Reid, Angew. Chem. Int. Ed, vol.57, pp.3022-3047, 2018.

W. J. Lockley, A. Mcewen, and R. Cooke, J. Label. Compd. Radiopharm, vol.55, pp.235-257, 2012.

J. Atzrodt, V. Derdau, W. J. Kerr, and M. Reid, Angew. Chem. Int. Ed, vol.57, pp.1758-1784, 2018.

G. F. Taylor and J. A. Kepler, J. Label. Compd. Radiopharm, vol.27, pp.683-690, 1989.

B. Chen, E. R. Jamieson, T. D. Tullius, ;. Jardine, M. M. Weidner et al., J. Label. Compd. Radiopharm, vol.12, pp.487-491, 1980.

K. R. Shelton and J. M. Clark, Biochemistry, vol.6, pp.2735-2739, 1967.

H. Sajiki, H. Esaki, F. Aoki, T. Maegawa, and K. Hirota, Synlett, pp.1385-1388, 2005.

). G. Pieters, C. Taglang, E. Bonnefille, T. Gutmann, C. Puente et al., Angew. Chem. Int. Ed, vol.53, pp.2986-2989, 2014.

). B. Chen, E. R. Jamieson, T. D. Tullius-;-b, ). J. Chattopadhyaya, S. Yamakage et al., Bioorg. Med. Chem. Lett, vol.12, pp.9669-9670, 1990.

). F. Balssa, Y. Bonnaire, J. Label, . Compd, and . Radiopharm, 33-41; b) Regarding caffeine 10, when using 5 mol% of the catalyst, only the incorporation of deuterium atoms resulting from the preferential coordination site N-9 is observed at positions 8 and 3 (N-CH3), vol.50, 2007.

F. C. Vidarabine-see:-d, T. H. Baker, . F. Haskell-;-g, J. A. Taylor, and . Kepler, J. Label. Compd. Radiopharm, vol.284, pp.683-690, 1977.

L. M. Martinez-prieto, E. A. Baquero, G. Pieters, J. C. Flores, E. Jesus et al., Acc. Chem. Res, vol.53, pp.376-384, 2017.

, One example of tritiation of nucleobase derivative (Famciclovir, vol.1

H. Yang, C. Zarate, W. N. Palmer, N. Rivera, D. Hesk et al., Ci/mmol) was described using Ni catalyzed HIE, vol.8, pp.10210-10218, 2018.

J. C. Burnett, J. J. Rossi, and K. Tiemann, Biotechnology J, vol.6, pp.1130-1146, 2011.

). A. Tafech, T. Bassett, D. Sparanese, C. H. Lee-;-b)-r, R. S. Yu et al., Curr. Med. Chem, vol.13, pp.48-59, 2003.

W. Marcucci, G. Stock, R. B. Dai, S. Klisovic, M. I. Liu et al., J. Clin. Oncol, vol.23, pp.3404-3411, 2005.

Z. J. Lin, W. Li, and G. Dai, J. Pharm. Biomed. Anal, vol.44, pp.330-341, 2007.

). B. Basiri, M. G. Bartlett-;-c)-a, B. Mcginnis, M. G. Chen, and . Bartlett, J. Chromatogr. B, vol.6, pp.1386-1389, 2008.

M. Hemsley, L. Ewles, and . Goodwin, Bioanalysis, vol.4, pp.1457-1469, 2012.

L. Ewles, A. Goodwin, T. Schneider, ). S. Rothhammer-hampl-;-g, A. Franzoni et al., J. Pharm. Biomed. Anal, vol.6, pp.300-307, 2014.

H. Kikuchi, K. Kakoi, K. Hirota, S. Kusano, and . Nagata, BMC Res. Notes, vol.11, pp.708-711, 2018.